TI-23-014: Provider’s Clinical Support System – Medications for Opioid Use Disorder
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Substance Abuse and Mental Health Services Adminis notices from 2023.
Substance Abuse and Mental Health Services Adminis offered grants of up to $1.5 million to the applicants described in the notice. It expected to make one award worth $1.5 million in total. Applications closed on May 8, 2023.
From the official notice on Grants.gov, last changed March 7, 2023. Checked November 7, 2026.
- Award ceiling$1.5 million
- Total funding$1.5 million
- Expected awards1
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | March 7, 2023 |
|---|---|
| Deadline | May 8, 2023 |
| Archived by Grants.gov | June 7, 2023 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Eligible applicants are professional associations authorized under Section 1263 of the Consolidated Appropriations Act, 2023 to carry out substance use disorder training of practitioners seeking or renewing registration from the Drug Enforcement Administration (DEA).
Is this a realistic fit?
- Past Substance Abuse and Mental Health Services Projects of Regional and National Significance awards averaged $2.3 million; this notice allows up to $1.5 million per award.
- Most of the program's money (55% over five years) went to state and local governments.
- No cost sharing or match is required.
What the grant funds
The purpose of this program is to provide training, guidance, and mentoring on the use of Medications for Opioid Use Disorder (MOUD). It is intended to enhance the capacity of healthcare and counseling professionals to identify and treat opioid use disorder (OUD).
Who has won Substance Abuse and Mental Health Services Projects of Regional and National Significance grants before
From fiscal 2021 to 2025, Substance Abuse and Mental Health Services Projects of Regional and National Significance (93.243) awarded $13 billion across 5,689 grant awards, an average of $2.3 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The Mental Health Association of New York City, Inc. | New York | 8 | $1.1 billion |
| California Department of Health Care Services | California | 6 | $502 million |
| Florida Department of Children and Families | Florida | 5 | $427 million |
| Ohio Department Mental Health | Ohio | 11 | $376 million |
| Pennsylvania Department of Drug and Alcohol Programs | Pennsylvania | 3 | $268 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is TI-23-014 still open?
No. It closed on May 8, 2023.
Who can apply for Provider’s Clinical Support System – Medications for Opioid Use Disorder?
Substance Abuse and Mental Health Services Adminis accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for Provider’s Clinical Support System – Medications for Opioid Use Disorder?
Closed May 8, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $1.5 million each. About $1.5 million in total for one award.
Who has won Substance Abuse and Mental Health Services Projects of Regional and National Significance grants before?
The largest recipients over five fiscal years were The Mental Health Association of New York City, Inc., California Department of Health Care Services, Florida Department of Children and Families. The program made 5,689 awards worth $13 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)